Syngeneic tumor models and human immune cell-engrafted mice are two of the popular preclinical tools in immuno-oncology studies.
There is no single “one size fits all” cell-based assay however 3D cell cultures have been shown to be more physiologically relevant in oncology, immune oncology and other fields.
Between preventative vaccines and palliative treatment for the sickest COVID-19 patients lies the realm of existing drugs that could be repurposed for antiviral prophylaxis.
During this webinar, Dr. Suzanne Riches highlights a variety of approaches for conducting virology assays in a high-throughput format.
Available on demand. In this informational webinar, Dr. Dmitry Kuksin, Nexcelom Senior Scientist, examines specific virology related assays such as plaque and foci formation, as well as antibody neutralization.
Is Your Lab Using High-throughput Image Cytometry to Expedite Viral Assay Development and Research of SARS-CoV-2?
Fast track vaccine development process by conducting assays in 96- or 384-well plates based on enumeration of foci, plaque or single infected cells.
Nexcelom's China team works with scientists in State Key Laboratory of Respiratory Diseases in China, for the screening of antiviral agents against SARS-CoV-2 virus, the cause of COVID-19 (Corona Virus).
Webinar on Demand: Role of Aneuploidy and DNA Damage in the Onset of Human Solid Tumors – Lessons from Mouse Models of Chromosome Losses
Available on demand. During this webinar, Dr. Thomas will share his research in cancer biology related to DNA damage in the onset of solid tumors.
In this webinar, we highlight a variety of assays to support the development of cell therapies for solid tumors.
Improved fluorescent plaque assay method using fluorescently-labeled antibodies and the use of the Celigo image cytometer.